Early Death May Be Common in Cancer Patients Taking Immune Checkpoint Inhibitors
Results of a real-world study suggest that early death may be common among cancer patients taking immune checkpoint inhibitors.
Melanoma
Melanoma News & Features
Cancer Patients With Diabetes May Have Worse Outcomes on ICIs
Cancer patients with type 2 diabetes may have worse survival outcomes on immune checkpoint inhibitor therapy, a new study suggests.
New Model Helps ID Melanoma Patients With Lymph Node Involvement
Patient-centered methodology-generated probabilities better identify patients eligible for sentinel lymph node biopsy than those generated by conventional logistic regression analysis.
Anti-PD-1 More Effective With Normal Vitamin D Levels in Melanoma
Significantly higher response rate and longer progression-free survival seen for patients with normal vitamin D.
Pembrolizumab May Be Treatment of Choice for Unresectable Desmoplastic Melanoma
In a phase 2 trial, pembrolizumab produced an overall response rate of 89% in patients with unresectable desmoplastic melanoma.
Melanoma Clinical Trials
Clinical Trial: Study of Tumor Tissue Samples From Patients With Stage I, Stage II, or Stage III Malignant Melanoma
Clinical Trial: Evaluating the Safety and the Biological Effects of Intratumoral Interferon Gamma and a Peptide-Based Vaccine in Patients With Melanoma (Mel 51)
Clinical Trial: Study of Families With Melanoma
Clinical Trial: Individualized Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
Clinical Trial: Combination Therapy of Topical Imiquimod Plus Multipeptide Vaccination for Cutaneous Metastases of Melanoma
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Melanoma
Loading... 
Loading...